Patton Fund Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,084
| Closed | -$4.06M | – | 91 |
|
|
2024
Q4 | $4.06M | Sell |
10,084
-1,515
| -13% | -$610K | 0.8% | 61 |
|
|
2024
Q3 | $5.39M | Sell |
11,599
-641
| -5% | -$298K | 1.11% | 39 |
|
|
2024
Q2 | $5.74M | Sell |
12,240
-2,418
| -16% | -$1.13M | 1.21% | 24 |
|
|
2024
Q1 | $6.13M | Buy |
+14,658
| New | +$6.13M | 1.11% | 29 |
|
|
2023
Q4 | – | Sell |
-6,309
| Closed | -$2.19M | – | 99 |
|
|
2023
Q3 | $2.19M | Sell |
6,309
-4,220
| -40% | -$1.47M | 0.59% | 31 |
|
|
2023
Q2 | $3.71M | Sell |
10,529
-796
| -7% | -$280K | 1.08% | 16 |
|
|
2023
Q1 | $3.57M | Buy |
11,325
+3,933
| +53% | +$1.24M | 1.02% | 16 |
|
|
2022
Q4 | $2.14M | Sell |
7,392
-295
| -4% | -$85.2K | 0.62% | 55 |
|
|
2022
Q3 | $2.23M | Buy |
+7,687
| New | +$2.23M | 0.9% | 24 |
|
|
2020
Q4 | – | Sell |
-6,129
| Closed | -$1.67M | – | 95 |
|
|
2020
Q3 | $1.67M | Sell |
6,129
-39
| -0.6% | -$10.6K | 0.9% | 40 |
|
|
2020
Q2 | $1.79M | Buy |
+6,168
| New | +$1.79M | 1.04% | 19 |
|